SpinaFX Medical’s Triojection earned the FDA’s breakthrough device designation, according to an Aug. 15 news release.
Triojection is a minimally invasive, image-guided procedure to reduce pressure within the disc and alleviate nerve compression for lumbar disc herniation patients.
With breakthrough designation, the flagship device will have prioritized access to the FDA for regulatory processes.
